Nine pharmacy organizations sent a July 9 letter to HHS Secretary Robert F. Kennedy Jr. warning the CDC’s June 25 revised charter for the Advisory Committee on Immunization Practices could undermine the evidence-based framework guiding U.S. immunization policy.  Here are…

The University of Southern California Mann School of Pharmacy and Pharmaceutical Sciences has received a $300,000 grant from the Centene Foundation and Health Net to expand services at its USC Pharmacy and Wellness Center in South Los Angeles. The funding…

The American Hospital Association has filed a friend-of-the-court brief supporting HHS’ motion to dismiss AbbVie’s lawsuit challenging the agency’s longstanding definition of “patient” under the 340B Drug Pricing Program.  The brief, filed July 14, argues AbbVie is attempting to bypass…

Drug costs are emerging as one of hospitals’ fastest-growing expense categories, outpacing labor and other nonlabor costs as organizations continue to navigate a challenging financial environment, according to Kaufman Hall’s latest “National Hospital Flash Report.” Nationally, drug expense per adjusted…

Active U.S. drug shortages increased to 227 in the second quarter of 2026, marking the third consecutive quarterly increase, according to a new report from the American Society of Health-System Pharmacists.  While shortages remain well below the record 323 reported…

The FDA has approved Merck’s Lipfendra (enlicitide), a once-daily oral therapy to reduce low-density lipoprotein cholesterol in adults with high cholesterol or heterozygous familial hypercholesterolemia. The approval was supported by two randomized, double-blind, placebo-controlled trials involving 3,207 adults already taking…

Ask pharmacy leaders to picture the elite team of the future and a common vision emerges: fewer workarounds, less time fighting the system, and more time spent on the clinical judgment and patient connection that only a person can provide.…

Health system and hospital pharmacy departments are heading into next year with a familiar set of pressures: a shrinking graduate pipeline, unpredictable drug shortages, evolving 340B and reimbursement rules, and the ongoing task of keeping experienced staff engaged. Becker’s asked…

Pediatric drugs are the most affected therapeutic category in active drug shortage with 16 shortages, and six of those involve IV fluids and additives — a challenge that hits children’s hospitals harder than most adult health systems.  A different kind…

Children’s Hospital of Philadelphia increased average monthly naloxone, known as Narcan, co-prescribing for patients receiving outpatient opioid prescriptions from 3% to 84.1% through an enterprisewide quality improvement initiative, according to a study published June 16 in The Journal of Pediatrics.…